Aidspan publishes new issue of 'Global Fund Observer'

NewsGuard 100/100 Score
Nov 21 2012

Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Monday published Issue 202 of its "Global Fund Observer." Among other articles, the issue features an article on the selection of Ambassador Mark Dybul as the next Global Fund executive director; an article summarizing "the main decisions made by the Global Fund Board at its 28th meeting in Geneva on 14-15 November 2012"; and an article on the Global Fund Board's approval of a new funding model (11/16).

http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Posted in: Disease/Infection News | Healthcare News

Tags: , , , ,

Comments (0)

Suggested Reading

The path to a better tuberculosis vaccine runs through Montana
Oxford University and Brazil partner to advance malaria vaccine development
Pioneering study launched to examine how the immune system responds to repeated malaria infections
WHO recommends R21/Matrix-M vaccine for malaria prevention in children
Innovative malaria prodrug targets liver, enhances efficacy while reducing toxicity, preclinical studies show
New study finds interferon-γ release assays more effective than skin tests in predicting tuberculosis
WHO releases an investment case for TB screening and preventive treatment
Enzymatic cocktail emerges as new hope against mycobacterial infections

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
New malaria vaccine strain shows promise in preclinical trials